Call now: (800) 597-5418


If you were diagnosed with uterine or abdominal cancer after a hysterectomy or surgery to remove uterine fibroids, you may be entitled to money damages!

Attention women diagnosed with cancer after a hysterectomy or surgery to remove uterine fibroids: did you know that some women undergoing hysterectomy or fibroid removal have low-stage uterine cancer that cannot be diagnosed before surgery, even with a biopsy? The FDA has announced that the power morcellator, a surgical tool often used in hysterectomies and the removal of uterine fibroids, may spread these undetected cancer cells to different parts of the body, rapidly advancing the cancer. If you or a loved one were diagnosed with abdominal cancer after a hysterectomy or surgery to remove uterine fibroids, call Burg Simpson at (800) 597-5418.

Our Services

Easily Customise

first-feature-image

sample paragraph content here.

Read More

WordPress Theme

second-feature-image

sample paragraph content here.

Read More

Easy Customise

third-feature-image

sample paragraph content here.

Read More

The FDA discourages the use of power morcellation for the removal of the uterus or uterine fibroids, citing reports that it may spread cancer cells to different parts of the body.

testimonial-image

The power morcellator, a surgical device popular for use in minimally invasive procedures for hysterectomies and the removal of uterine fibroids, had appealing qualities for surgeons and patients. It is used during laparoscopic or robotic assisted operations that can be performed in less time, require only small incisions—about 2 centimeters—and involve less pain, a shorter hospital stay and a faster recovery. Unfortunately, the procedure poses a dangerous risk of spreading undetected cancer cells.

According to the FDA, about 1 in 350 women who undergo hysterectomy or surgery for uterine fibroids have an unsuspected, undetectable type of uterine cancer called uterine sarcoma or leiomyosarcoma. If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, rapidly advancing the cancer.

Johnson & Johnson, which represents a majority of the market for the power morcellators, originally stood by the device but later suspended sales of its product, and more recently asked hospitals to return the devices through a "worldwide market withdraw."

The Food and Drug Administration (FDA) announced, in April 2014, that it discourages the use of laparoscopic power morcellation for hysterectomy or removal of uterine fibroids due to reports that it may spread cancer cells.

If you or a loved one were diagnosed with uterine or abdominal cancer after a hysterectomy or surgery to remove uterine fibroids, you may be entitled to money damages. Call Burg Simpson now at (800) 597-5418. Our phone lines are open 24 hours a day. We'll give you a free, no-obligation case evaluation to determine whether you may be eligible for compensation.

 

Get a FREE, no-obligation morcellator cancer risk case evaluation:

Best time to reach you:
Tell us about your injuries:
  • Your time to act is limited! Call now: (800) 597-5418 Mon-Fri: 10am-11pm And Sat-Sun: 11am-9pm
  • # #

Please remember that there is no attorney-client relationship until you and the law firm sign a written retainer agreement. Please see our disclaimers page for important information.